Kymera Therapeutics (KYMR) Ownership - Who owns Kymera Therapeutics?

11 days until earnings call

Profile

Industry
N/A
Address
200 Arsenal Yards Boulevard
Phone
+1 857 285-5300
Employees
187
Web
https://www.kymeratx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.64B
P/E Ratio
N/A
Total Cash
520.54M
Projected Growth
N/A
Total Debt
87.02M
Revenue
79.41M
Risk (Beta)
2.34
Dividend Yield
N/A
Total Cash/Share
8.48
Total Debt/Equity
N/A
Revenue/Share
1.29 USD as % of share price

Fundamentals

KYMR
Capitalization
2.65B
P/E Ratio
N/A
Risk (Beta)
2.34
Dividend Yield
N/A
Total Cash
521M
Total Cash/Share
8.48
Total Debt
87M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.29%
Revenue
79.4M
ROE
N/A
Book Value
711M
P/B Ratio
3.72
Cash Flow
N/A
Earnings
-2.51
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
9.57
Current Revenue Per Employee
55306.45
Dividends Per Share - Security
N/A
EBITDA
-150.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.86
Shares Held By Institutions
3.15B
Shares Outstanding - Current
61.4M
Total Liabilities
157M
Total Volume MTD
N/A
Value
-1
Gain YTD
69.285
View a ticker or compare two or three
KYMR
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biotechnology company, which engages in curing untreatable diseases and focuses on discovering and developing novel small molecule therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
200 Arsenal Yards Boulevard
Phone
+1 857 285-5300
Employees
187
Web
https://www.kymeratx.com